Skip to Main Content

Anne Wyllie, PhD

Research Scientist in Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health; Member, Center for Infection and Immunity

Contact Information

Anne Wyllie, PhD

Office Location

  • Yale School of Public Health (LEPH)
    60 College Street
    New Haven, CT 06510



As compared to the gold standard nasopharyngeal swab, Dr. Wyllie’s work has identified saliva as a reliable sample type for the sensitive detection of Streptococcus pneumoniae (the pneumococcus) in healthy older adults and more recently, SARS-CoV-2 in persons suspected of COVID-19. Improved detection of the pneumococcus has unveiled hidden reservoirs of pneumococcus in older adults which holds importance when new vaccination strategies for preventing pneumococcal disease are being considered. For COVID-19, sampling saliva can alleviate many of the bottlenecks encountered in the mass testing strategies required to control continuing outbreaks. In an effort to address many of these issues, Wyllie further validated and optimized saliva for SARS-CoV-2 detection and developed SalivaDirect: a simple, scalable and importantly, cost-effective method to help alleviate SARS-CoV-2 testing demands.

Education & Training

  • PhD
    Utrecht University, Medical Microbiology (2016)
  • MBioMedSci
    University of Auckland, Cancer Immunology (2009)
  • BMedSci
    University of Auckland, Immunology and Microbiology (2007)

Honors & Recognition

AwardAwarding OrganizationDate
Young Investigator Award in Clinical Microbiology and Infectious DiseasesEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID)2023
Unlocking Potential GrantMicrobiology Society2022
2021 Outstanding Manuscript of the YearThe Association of Biomolecular Resource Facilities2022
World Changing Ideas: FinalistFast Company2022
COVID-19 Research AwardYale School of Public Health2021
Medal of ExcellenceNorthcote College Board of Trustees2020

Departments & Organizations